Clinical Trial Update: Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis [NA]

View source ↗

Summary

A completed clinical trial evaluated a novel chitosan hemostatic sealant for complicated nosebleeds, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis

Drugs mentioned

• Chitosan Hemostatic Sealant (Chitosan-based hemostatic sealant)

Snippet

Sponsor: HemCon Medical Technologies, Inc | Conditions: Epistaxis | NA | Status: COMPLETED | Results posted: 2012-11-28